Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CAH vs GSK✓SelectedUSD · GSKCAH vs GSK performance historyLatest closeAs of+0.98%11/16
Stock and ETF performance explorer

CAH vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+17,548.4%
GSK return
+1,741.1%
Excess return
+15,807.3%
Maximum drawdown
-62.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+1.0%-0.1%+1.1%+1.0%
7D+3.5%-1.3%+4.8%+3.9%
30D+11.7%+2.7%+9.0%+10.6%
3M+21.0%+2.7%+18.3%+19.6%
6M+46.1%+3.3%+42.7%+43.9%
YTD+39.4%+6.5%+33.0%+35.5%
1Y+39.5%+10.7%+28.9%+33.8%
3Y+186.8%+64.4%+122.5%+136.3%
5Y+528.0%+46.7%+481.3%+429.5%
10Y+427.6%+109.4%+318.3%+293.2%
All+17,548.4%+1,741.1%+15,807.3%+7,998.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling